NKARTA INC (NKTX)
NASDAQ • Healthcare
Last close at August 10, 2026 at 20:00 UTC
Fundamentals Charts
About NKARTA INC
Nkarta, Inc. is a NASDAQ-listed Biotechnology company in the healthcare sector developing cell therapies built from natural killer cells, with work aimed at treating cancer and autoimmune disease. In qualitative terms, it is a clinical-stage biotech, and the company went public in 2020.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
NKARTA INC's Technical Indicators Summary
NKTX displays a cautiously constructive technical picture with the current price trading above short-term moving averages while remaining below the mid- and longer-term 50–100 day levels, and the 200-day average sits just under price. Momentum readings have turned mildly positive and OBV is supportive, though ADX shows only a weak trend and MACD is near neutral. Volatility is elevated with an ATR near 7.2 percent, which increases trade noise. The classic pivot is close by and not a clear bias. Technical takeaway: Buy — short-term momentum and volume support the constructive bias despite limited trend strength.
| Indicator | Value |
|---|---|
RSI (14) | 49.60 |
Stochastic %K (14, 3, 3) | 59.03 |
CCI (20) | 25.44 |
WPR (14) | -22.64 |
Momentum (10) | 0.20 |
MFI | 43.44 |
MACD Level (12, 26) | -0.13 |
Bollinger Bands | $1.98 - $2.74 |
ATR (14) | $0.18 (7.24%) |
ADX (14) | 15.92 |
OBV | 13,197,810 |
Classic Pivot Point | $2.39 |
Fibonacci Pivot Point | $2.39 |
Simple Moving Averages | $2.24 - $2.68(5 indicators) |
Exponential Moving Averages | $2.32 - $2.60(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
NKTX added to its momentum in the last session, ending 2.07% stronger at 2.46. NKTX gains traction after TD Cowen keeps Buy on Nkarta, signaling ongoing analyst support.
Trading Volume
Below 10d avg (665.2K)
510.2K
vs S&P 500 Today
Outperforming Market
+2.13%
52-Week Position
Mid-range
37.6%
Updated: August 11, 2026 at 12:14 UTC